Vytorin Has Double Duty
Kidney disease patients face a high risk of heart-related events like stroke. As such, patients need ways to protect against potentially deadly problems. Now, health advisors are backing a drug that does just that.
(UPDATE 12/15) FDA Announces New Safety Recommendations For High-Dose Simvastatin
The U.S. Food and Drug Administration today is announcing safety label changes for the cholesterol-lowering medication simvastatin because the highest approved dose--80 milligram (mg)--has been associated with an elevated risk of muscle injury or myopathy , particularly during the first 12 months of use.